Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma
Abstract Background We propose a new approach for designing personalized treatment for colorectal cancer (CRC) patients, by combining ex vivo organoid efficacy testing with mathematical modeling of the results. Methods The validated phenotypic approach called Therapeutically Guided Multidrug Optimiz...
Main Authors: | George M. Ramzy, Maxim Norkin, Thibaud Koessler, Lionel Voirol, Mathieu Tihy, Dina Hany, Thomas McKee, Frédéric Ris, Nicolas Buchs, Mylène Docquier, Christian Toso, Laura Rubbia-Brandt, Gaetan Bakalli, Stéphane Guerrier, Joerg Huelsken, Patrycja Nowak-Sliwinska |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-023-02650-z |
Similar Items
-
FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells
by: George M. Ramzy, et al.
Published: (2022-09-01) -
Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma
by: George M. Ramzy, et al.
Published: (2020-05-01) -
High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer
by: Maxim Norkin, et al.
Published: (2021-04-01) -
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment
by: Marloes Zoetemelk, et al.
Published: (2020-11-01) -
Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
by: Magdalena Rausch, et al.
Published: (2021-08-01)